New DNA reader could crack unsolved rare disease cases

NCT ID NCT07400913

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new DNA sequencing method that reads long stretches of DNA to find hidden genetic changes causing rare diseases like albinism and intellectual disability. Researchers will analyze stored blood or DNA from 150 patients who haven't gotten a clear diagnosis yet. The goal is to see if this approach can detect methylation abnormalities (epimutations) that standard tests miss, potentially reducing diagnostic dead ends.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALBINISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Bordeaux - Hôpital Pellegrin

    Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.